Aktis Oncology, Inc. of BOSTON, MA, a company, filed a Form D exempt-offering notice with the SEC on 2024-10-02. The offering totals $175.0M, of which $175.0M was reported sold. Industry: Biotechnology.
| Name | Role | Location |
|---|---|---|
| Todd Foley | Director | South San Francisco, CA |
| Ken S Herrmann | Director | Boston, MA |
| Helen S Kim | Director | Menlo Park, CA |
| Andrew S Levin | Director | Boston, MA |
| Oleg Nodelman | Director | San Francisco, CA |
| Matthew Roden | Director | Boston, MA |
| Lloyd S Segal | Director | Boston, MA |
| Matthew Roden | Executive Officer | Boston, MA |
| Shulamit S Ron-Bigger | Executive Officer | Boston, MA |